Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Axillary Lymph Node Identification Before Neoadjuvant Chemotherapy Using Magtrace, (Superparamagnetic Iron Oxide Nanoparticles, SPIO) and Magseed, in Clinically Node Negative and Node Positive Patients. SentiNeo 2.0

NCT06104371 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT06104371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06104371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Axillary Lymph Node Identification Before Neoadjuvant Chemotherapy Using Magtrace, (Superparamagnetic Iron Oxide Nanoparticles, SPIO) and Magseed, in Clinically Node Negative and Node Positive Patients. SentiNeo 2.0
Lead sponsor
Vastra Gotaland Region
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2025
Completion date
December 31, 2028
Enrollment
459 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer